Bridge To Life
Status
Current portfolio
Investment type
Growth Buy-out
Investment date
August 2026
Location
Duluth, Georgia, USA

Bridge to Life™ Ltd. is a global leader in organ preservation and perfusion technology. Driven by a commitment to science-based innovation, the company empowers transplant teams with advanced tools that expand the donor pool, streamline clinical workflows, and improve patient outcomes worldwide. VitaSmart™ joins a preservation franchise anchored by Belzer UW®, widely regarded as the global gold standard in cold static preservation and the most extensively used cold flush solution in abdominal organ transplantation. Together, the portfolio gives Bridge to Life a differentiated position spanning both established preservation and next generation machine perfusion.

This financing marks an important milestone for Bridge to Life and reflects the confidence our investors have in our technology, team, and long-term growth strategy.

Don WebberCEO and President of Bridge To Life
Lauxera Capital Partners Invests in Bridge To Life to Back the Next Chapter in Organ Preservation

Lauxera Capital Partners Invests in Bridge To Life to Back the Next Chapter in Organ Preservation

12 August 2026
GenePlanet

GenePlanet

Digital health integration — Lauxera Growth I
Antaros Medical

Antaros Medical

Imaging drug development — Lauxera Growth II
Acandis

Acandis

Neurovascular medical devices — Lauxera Growth II
Synovo Group

Synovo Group

Patient transportation software — Lauxera Growth I
Natural Cycles

Natural Cycles

Non-hormonal contraception — Lauxera Growth I
BioLamina

BioLamina

Regenerative medicine tools — Lauxera Growth I
OrganOx

OrganOx

Liver transplant optimization — Lauxera Growth I
Verdot

Verdot

Bioprocess purification platforms — Lauxera Growth I
Veranex

Veranex

Medtech innovation services — Lauxera Growth I
Matrix One

Matrix One

Medtech compliance platform — Lauxera Growth I
Reapplix

Reapplix

Advanced wound care — Lauxera Growth I
Lifen

Lifen

Digital health integration — Lauxera Growth I
Ospi

Ospi

Healthtech data intelligence — Lauxera Growth I
LUMICKS

LUMICKS

Protein and cell analysis — Lauxera Growth I
Caresyntax

Caresyntax

Surgical intelligence platform — Lauxera Growth I